- Home
- WYY vs JSPR Comparison
WYY vs JSPR Comparison
Compare WYY & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- JSPR
- Stock Information
- Founded
- WYY 1991
- JSPR 2018
- Country
- WYY United States
- JSPR United States
- Employees
- WYY N/A
- JSPR N/A
- Industry
- WYY EDP Services
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WYY Technology
- JSPR Health Care
- Exchange
- WYY Nasdaq
- JSPR Nasdaq
- Market Cap
- WYY 55.2M
- JSPR 47.6M
- IPO Year
- WYY 1998
- JSPR N/A
- Fundamental
- Price
- WYY $5.43
- JSPR $2.38
- Analyst Decision
- WYY Strong Buy
- JSPR Buy
- Analyst Count
- WYY 2
- JSPR 12
- Target Price
- WYY $7.50
- JSPR $30.78
- AVG Volume (30 Days)
- WYY 94.3K
- JSPR 150.8K
- Earning Date
- WYY 11-12-2025
- JSPR 11-06-2025
- Dividend Yield
- WYY N/A
- JSPR N/A
- EPS Growth
- WYY N/A
- JSPR N/A
- EPS
- WYY N/A
- JSPR N/A
- Revenue
- WYY $144,421,640.00
- JSPR N/A
- Revenue This Year
- WYY $9.19
- JSPR N/A
- Revenue Next Year
- WYY $13.16
- JSPR N/A
- P/E Ratio
- WYY N/A
- JSPR N/A
- Revenue Growth
- WYY 16.25
- JSPR N/A
- 52 Week Low
- WYY $2.19
- JSPR $2.27
- 52 Week High
- WYY $6.25
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- WYY 70.99
- JSPR 27.23
- Support Level
- WYY $4.65
- JSPR $2.50
- Resistance Level
- WYY $5.75
- JSPR $2.87
- Average True Range (ATR)
- WYY 0.31
- JSPR 0.13
- MACD
- WYY 0.04
- JSPR -0.01
- Stochastic Oscillator
- WYY 78.38
- JSPR 8.96
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.